SCM
Soleus Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
+78,800
| New | +$2.47M | 0.16% | 72 |
|
|
2024
Q1 | – | Sell |
-58,000
| Closed | -$2.67M | – | 101 |
|
|
2023
Q4 | $2.67M | Buy |
58,000
+6,000
| +12% | +$276K | 0.3% | 51 |
|
|
2023
Q3 | $1.78M | Sell |
52,000
-14,000
| -21% | -$478K | 0.16% | 69 |
|
|
2023
Q2 | $2.54M | Buy |
+66,000
| New | +$2.54M | 0.28% | 65 |
|
|
2023
Q1 | – | Sell |
-38,000
| Closed | -$1.5M | – | 99 |
|
|
2022
Q4 | $1.5M | Sell |
38,000
-58,800
| -61% | -$2.32M | 0.22% | 63 |
|
|
2022
Q3 | $3.49M | Buy |
96,800
+21,800
| +29% | +$787K | 0.47% | 48 |
|
|
2022
Q2 | $2.28M | Sell |
75,000
-114,797
| -60% | -$3.49M | 0.36% | 56 |
|
|
2022
Q1 | $5.8M | Sell |
189,797
-189,200
| -50% | -$5.78M | 0.75% | 38 |
|
|
2021
Q4 | $11.8M | Buy |
378,997
+163,300
| +76% | +$5.1M | 1.19% | 25 |
|
|
2021
Q3 | $3.3M | Sell |
215,697
-18,000
| -8% | -$275K | 0.51% | 46 |
|
|
2021
Q2 | $4.35M | Sell |
233,697
-474,420
| -67% | -$8.83M | 0.67% | 31 |
|
|
2021
Q1 | $12.7M | Buy |
708,117
+150,000
| +27% | +$2.68M | 2.28% | 9 |
|
|
2020
Q4 | $8.58M | Buy |
558,117
+57,853
| +12% | +$890K | 1.13% | 9 |
|
|
2020
Q3 | $5.54M | Buy |
500,264
+249,367
| +99% | +$2.76M | 2.94% | 14 |
|
|
2020
Q2 | $3.15M | Buy |
250,897
+237,669
| +1,797% | +$2.98M | 1.79% | 20 |
|
|
2020
Q1 | $150K | Sell |
13,228
-148,372
| -92% | -$1.68M | 0.17% | 47 |
|
|
2019
Q4 | $2.12M | Buy |
+161,600
| New | +$2.12M | 2.04% | 19 |
|